408 related articles for article (PubMed ID: 29361616)
1. [Onco-Cardiology - From the Standpoint of Cardiology].
Shioyama W
Gan To Kagaku Ryoho; 2017 Dec; 44(13):2052-2057. PubMed ID: 29361616
[TBL] [Abstract][Full Text] [Related]
2. [Management of Cancer Patients with Cardiovascular Complications - Onco-Cardiology].
Mukai M
Gan To Kagaku Ryoho; 2016 Aug; 43(8):940-4. PubMed ID: 27539035
[TBL] [Abstract][Full Text] [Related]
3. Cardioncology: state of the heart.
Todaro MC; Oreto L; Qamar R; Paterick TE; Carerj S; Khandheria BK
Int J Cardiol; 2013 Sep; 168(2):680-7. PubMed ID: 23639459
[TBL] [Abstract][Full Text] [Related]
4. Curing Cancer, Saving the Heart: A Challenge That Cardioncology Should Not Miss.
Cardinale D; Biasillo G; Cipolla CM
Curr Cardiol Rep; 2016 Jun; 18(6):51. PubMed ID: 27108361
[TBL] [Abstract][Full Text] [Related]
5. Onco-cardiology: Present and future.
Sueta D; Hokimoto S
Int J Cardiol; 2016 Jul; 215():38-40. PubMed ID: 27107544
[TBL] [Abstract][Full Text] [Related]
6. Practices in management of cancer treatment-related cardiovascular toxicity: A cardio-oncology survey.
Jovenaux L; Cautela J; Resseguier N; Pibarot M; Taouqi M; Orabona M; Pinto J; Peyrol M; Barraud J; Laine M; Bonello L; Paganelli F; Barlesi F; Thuny F
Int J Cardiol; 2017 Aug; 241():387-392. PubMed ID: 28365180
[TBL] [Abstract][Full Text] [Related]
7. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
Lenneman CG; Sawyer DB
Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
[TBL] [Abstract][Full Text] [Related]
8. Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome.
Tilemann LM; Heckmann MB; Katus HA; Lehmann LH; Müller OJ
Clin Res Cardiol; 2018 Apr; 107(4):271-280. PubMed ID: 29453595
[TBL] [Abstract][Full Text] [Related]
9. Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues.
Zambelli A; Della Porta MG; Eleuteri E; De Giuli L; Catalano O; Tondini C; Riccardi A
Breast; 2011 Apr; 20(2):176-83. PubMed ID: 21146409
[TBL] [Abstract][Full Text] [Related]
10. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
[TBL] [Abstract][Full Text] [Related]
11. Cardiology consultation in oncology practice: a 5-year survey.
Tajiri K; Sekine I; Naito H; Murata M; Li S; Inoue K; Sasamura R; Nakajima H; Iida N; Nagashio K; Honda J; Murakoshi N; Ishizu T; Ieda M
Jpn J Clin Oncol; 2020 Dec; 50(12):1419-1425. PubMed ID: 32676637
[TBL] [Abstract][Full Text] [Related]
12. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
[TBL] [Abstract][Full Text] [Related]
13. Clinical vignettes: integrated care of cancer patients by oncologists and cardiologists.
Hofstatter E; Saadati H; Russell K; Russell R
Curr Cardiol Rev; 2011 Nov; 7(4):258-61. PubMed ID: 22758627
[TBL] [Abstract][Full Text] [Related]
14. A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology.
Spallarossa P; Maurea N; Cadeddu C; Madonna R; Mele D; Monte I; Novo G; Pagliaro P; Pepe A; Tocchetti CG; Zito C; Mercuro G
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1(Suppl 1):S84-92. PubMed ID: 27183529
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular Toxicities in Pediatric Cancer Survivors.
Ryan TD; Nagarajan R; Godown J
Cardiol Clin; 2019 Nov; 37(4):533-544. PubMed ID: 31587793
[TBL] [Abstract][Full Text] [Related]
16. Assessment of cardiotoxicity with cardiac biomarkers in cancer patients.
Cardinale D; Cipolla CM
Herz; 2011 Jun; 36(4):325-32. PubMed ID: 21562775
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management.
Yeh ET; Bickford CL
J Am Coll Cardiol; 2009 Jun; 53(24):2231-47. PubMed ID: 19520246
[TBL] [Abstract][Full Text] [Related]
18. The Future of Onco-Cardiology: We Are Not Just "Side Effect Hunters".
Abe J; Martin JF; Yeh ET
Circ Res; 2016 Sep; 119(8):896-9. PubMed ID: 27688305
[TBL] [Abstract][Full Text] [Related]
19. Fluoropyrimidine-Induced Cardiotoxicity: Manifestations, Mechanisms, and Management.
Layoun ME; Wickramasinghe CD; Peralta MV; Yang EH
Curr Oncol Rep; 2016 Jun; 18(6):35. PubMed ID: 27113369
[TBL] [Abstract][Full Text] [Related]
20. Cancer Therapeutics-Related Cardiac Dysfunction - Insights From Bench and Bedside of Onco-Cardiology.
Kadowaki H; Akazawa H; Ishida J; Komuro I
Circ J; 2020 Aug; 84(9):1446-1453. PubMed ID: 32727978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]